10:05 AM EDT, 05/01/2025 (MT Newswires) -- Organon (OGN) shares declined 22% in recent Thursday trading after the company reported Q1 adjusted earnings of $1.02 per diluted share, down from $1.22 a year earlier.

Analysts polled by FactSet expected $0.89.

Revenue for the quarter ended March 31 was $1.51 billion, down from $1.62 billion a year earlier.

Four analysts surveyed by FactSet expected $1.51 billion.

The company said it maintained its 2025 revenue outlook of $6.13 billion to $6.33 billion. Analysts surveyed by FactSet expect $6.29 billion.

Price: 9.40, Change: -3.54, Percent Change: -27.34